Mr. Blank has over twenty years of regulatory affairs experience with a wide variety of medical devices including interventional cardiology products (including drug-eluting stents), endovascular products, cardiac rhythm management devices, ophthalmic surgical equipment, durable emergency care equipment, general surgical tools and cardiothoracic devices. Mr. Blank has experience in developing and executing regulatory strategies and tactics to navigate the product approval and post-approval processes. He also has experience in performing due diligence on potential investment opportunities as well as identifying steps to improve the effectiveness and efficiency of global regulatory affairs organizations.
Tony led the cardiovascular regulatory affairs organizations at Boston Scientific, a medical technology company that develops, manufactures, and markets medical devices used in various interventional medical specialties. His experience also includes positions with Summit Technology, Cardiac Control Systems and Cobe Laboratories. He has a proven track record in developing world-class regulatory organizations, advocating on regulatory policy issues, and successfully navigating global medical device regulatory processes. Mr. Blank has in-depth experience in interventional cardiology, endovascular, ophthalmic, vascular access, cardiac rhythm management and general surgical products.